FindTrial
Sign In

A Study to Assess Whether Adding Tramadol Improves Pain Relief After Breast Cancer Surgery

Evaluation of Tramadol as an Adjuvant to Ropivacaine in Ultrasound Guided Serratus Anterior Muscle Block for Modified Radical Mastectomy - EXTRA-SAM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100138
Enrollment
50
Registered
2026-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: tramadol: patients will recieve tramadol as adjuvant to ropivacaine 0.25% in serratus anterior mucle block for modified radical mastectomy Control Intervention1: saline: patients will r

Sponsors

Guru Gobind Singh Medical College Hospital, Faridkot
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age group between 18 to 80 years. American Society of Anaesthesiologist (ASA) physical status I and II. Patients giving valid, informed and written consent.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To compare post operative analgesic consumption over 24 hour in patients recieving ultra sound guided serratus anterior muscle block with 0.25% ropivacaine with tramadol as adjuvant and without tramadol as adjuvantTimepoint: pain free time (hours)—

Secondary

MeasureTime frame
time to first analgesic requestTimepoint: time to first analgesic request(hours)—

Countries

India

Contacts

Public ContactDr Srishti Jindal

Guru Gobind Singh Medical College Hospital, Faridkot

kkgupta@ggsmch.org9781812052

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026